Exclusive webinar and Q&A – Acamar Films EIS (Bing)

Wealth Club members are invited to an exclusive investor webinar and Q&A with the CEO of Acamar Films, Mikael Shields. 

The company produces and owns the IP assets of the BBC chart-topping children’s show Bing. The current round of Acamar Films EIS is now in overfunding.

The show enjoys a devoted fan following amongst pre-schoolers. As a business, Acamar’s achievements are impressive, in our view. In just six years it has reached 119 territories worldwide with its show and licensed products. Underlying trading revenues have pretty much doubled each year since 2017 – from £0.4 million to £3.3 million to May 2020 (past performance is not a guide to the future). 

How much further could Bing grow? How is the global health crisis impacting Acamar? What are the challenges and opportunities?

The first session was fully booked within a day. To accommodate demand, we have now organised a second session at 4.30pm on 30 July 2020. It could be an excellent chance for you to hear directly from Mikael – and ask him questions. Places at this live event are limited, and for Wealth Club members only.

Mikael has committed 15 years and several millions of his own and family’s money to set Bing on this journey to global success, bringing his 30 years’ team-leading experience in film and television to bear.

Don’t miss this opportunity to hear more from Mikael and engage with him on the future of the business, its challenges, progress and potential.

Places at this live event are limited, and for Wealth Club members only.

Investor webinar and Q&A (Thu 30 July, 4.30pm) – please complete the form below to confirm your place today

Who will be attending?

Wealth Club aims to make it easier for experienced investors to find information on – and apply for – tax-efficient investments. You should base your investment decision on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.